Kikuchi S, Negoro E, Horaguchi R, Fujihira T, Nabe Y, Minemura T, Ono K, Kamihara Y, Wada A, Dang NH, Masaki Y, Miyamoto T, Yamauchi T, Sato T. Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial). Haematologica; https://doi.org/10.3324/haematol.2026.300564 [Early view].